tiprankstipranks
Nanobiotix SA (FR:NANO)
:NANO
France Market
NANO
Nanobiotix
RESEARCH TOOLSreports
Want to see FR:NANO full AI Analyst Report?

Nanobiotix (NANO) Stock News & Sentiment

30 Followers
Premium
Ratings
Nanobiotix: Platform Expansion Potential and Risk-Adjusted NBTXR3 Valuation Support Buy Rating
29d ago
NBTX
Premium
Company Announcements
Nanobiotix Earnings Call: Deeper J&J Ties, Lower Loss
1M ago
Nanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile
Premium
Ratings
Nanobiotix: Late-Stage NBTXR3 Pipeline and Partnerships Underpin Buy-Rated Risk-Reward Profile
2M ago
NBTX
Robust Phase 2 CONVERGE Data for JNJ-1900 Underpin Buy Rating and €32 Price Target on Nanobiotix
Premium
Ratings
Robust Phase 2 CONVERGE Data for JNJ-1900 Underpin Buy Rating and €32 Price Target on Nanobiotix
2M ago
NBTX
Nanobiotix: Differentiated Radiotherapy Enhancer, J&J Partnership, and Multi-Indication Pipeline Undervalue Long-Term Upside, Supporting Buy Rating
Premium
Ratings
Nanobiotix: Differentiated Radiotherapy Enhancer, J&J Partnership, and Multi-Indication Pipeline Undervalue Long-Term Upside, Supporting Buy Rating
3M ago
NBTX
Undervalued Royalty Stream and De‑Risked Partnership Economics Underpin Nanobiotix Buy Rating
Premium
Ratings
Undervalued Royalty Stream and De‑Risked Partnership Economics Underpin Nanobiotix Buy Rating
4M ago
NBTX
Strategic Financial and Operational Advancements Propel Nanobiotix to a Buy Rating
Premium
Ratings
Strategic Financial and Operational Advancements Propel Nanobiotix to a Buy Rating
6M ago
NBTX
More FR:NANO News >

NANO News on the Web

Nanobiotix price target raised to EUR 60 from EUR 34 at H.C. Wainwright
TipRanks News
Neutral
Assessing Nanobiotix (ENXTPA:NANO) Valuation After FDA Protocol Amendment For Key Phase 3 Cancer Study
Simply Wall St
Bullish
Guggenheim Remains a Buy on Nanobiotix (NBTX)
TipRanks News
Bullish
Nanobiotix announces FDA acceptance of NANORAY-312 study protocol amendment
TipRanks News
Bullish
Nanobiotix price target raised to $30 from $3.50 at UBS
TipRanks News
Neutral
Nanobiotix: Platform Expansion Potential and Risk-Adjusted NBTXR3 Valuation Support Buy Rating
TipRanks News
Bullish
Nanobiotix Nanoprimer Data Add New Dimension To Cancer Platform Story
Simply Wall St
Neutral
Nanobiotix price target raised to EUR 34 from EUR 32 at H.C. Wainwright
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
FR:NANO
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.5 articles
News Sentiment
This Week100%
Sector Average81%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FR:NANO’s Media Buzz Sentiment?
3 articles about FR:NANO were published this week. In an average week, 1.5 articles are published.
    What is FR:NANO’s weekly average amount of articles?
    In an average week, 1.5 articles about FR:NANO are published.
      What is FR:NANO’s News Sentiment?
      100% of articles about FR:NANO were positive this week, compared to its sector average of 81%.
        General Stocks that are Trending in the News
        YSWYYesway Inc Class A
        XEX-Energy, Inc. Class A
        NHPNational Healthcare Properties
        FPSForgent Power Solutions, Inc. Class A
        MRVMarvell Technology Inc Sponsored Canadian Depository Receipt Hedged
        Showing the stocks with the most bullish news sentiment over the past week